Liver transplant

3 trials MedDRA PT
3 Registered trials
0 Recruiting
3 Unique sponsors
4 Unique IMPs
2 Commercial trials
Drug classes (ATC)
B Haematology (ATC B) 1
ATC code not specified 1
A Gastroenterology (ATC A) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Immunosuppressant 1 substance
Azole antifungal 1 substance
Phase III: 1 Phase I/II: 1 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Dr. Franz Koehler Chemie GmbH Commercial
    ALANINE, ARGININE, DEFEROXAMINE, HISTIDINE, ASPARTIC ACID, GLYCINE, TRYPTOPHAN, SUCROSE, CALCIUM, MAGNESIUM, POTASSIUM, SODIUM, N-HYDROXY-3,4-DIMETHOXY-N-METHYL-BENZAMIDE, N-ACETYLHISTIDINE, CHLORIDE ION, OXOGLURIC ACID; MANNITOL, HISTIDINE, HISTIDINE HYDROCHLORIDE MONOHYDRATE, TRYPTOPHAN, MAGNESIUM CHLORIDE HEXAHYDRATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE DIHYDRATE, OXOGLURIC ACID
    2024-518174-13-00 1 country 2024 n=200
    Ended

Phase I/II

1 trial
  • Mimetech S.r.l. Commercial
    IMP not specified
    2023-508977-10-00 1 country n=24
    Pending

Phase IV

1 trial
  • Leids Universitair Medisch Centrum (LUMC) Academic
    MYCOPHENOLATE MOFETIL; PANTOPRAZOLE
    2024-517043-32-00 1 country 2025 n=12
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Dr. Franz Koehler Chemie GmbH Commercial 1 Phase III 0
Mimetech S.r.l. Commercial 1 Phase I/II 0
Leids Universitair Medisch Centrum (LUMC) Academic 1 Phase IV 0
New trials by year
2024
1
2025
1
← All indication landscapes